Edwards Lifesciences upgraded to Buy from Hold at Stifel
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...
Crowdfund Insider22h
OurCrowd Recognized Again as Most Active Venture Investor in Israel, Once Again: 68 Exits to Date
Online investment platform OurCrowd has once again been recognized as the most active venture investor in Israel - which ...
Globus Medical stock soars to all-time high of $93.68
Globus Medical Inc. (NYSE:GMED) shares have reached an unprecedented peak, touching an all-time high of $93.68. With a market capitalization of $12.7 billion and an impressive revenue growth of 102.1% ...
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Jefferies analyst Kaumil Gajrawala upgraded the rating for The Coca-Cola Company KO from Hold to Buy and increased the price target from $69 to $75. Coca-Cola shares closed at $62.83 on Wednesday. See ...
Indiatimes17h
Eris Lifesciences Share Price
Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 15,697.07 Crore) operating in Pharmaceuticals sector. Eris Lifesciences Ltd. key Products/Revenue ...